Skip to main content

Advertisement

Log in

Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Objective

The aim of this study is to evaluate neurofibromatosis type 1 (NF1) patients with whole-body MRI (WBMRI) to investigate the frequency of plexiform neurofibromas (pNFs), diffuse neurofibromas (dNFs), and malignant peripheral nerve sheath tumors (MPNSTs).

Materials and methods

In this retrospective cross-sectional study, between the years 2015 and 2023, 83 consecutive patients with known NF1 underwent a total of 110 WBMRI screenings for MPNST using a standardized institutional protocol. The lesions are categorized as discrete lesions, pNFs, dNFs, and MPNSTs. Histopathology served as the reference standard for all MPNSTs.

Results

Among the 83 patients analyzed, 53 (64%) were women and 30 were men (36%) of ages 36.94±14.43 years (range, 15–66 years). Of the 83 patients, 33 have a positive family history of NF1 and positive genetic studies. Seven of 83 (8%) have only dNF, 20/83 (24%) have pNF, 28/83 (34%) have both dNF and pNF, and 28/83 (34%) have neither. Of the 83 patients, eight (9.6%) were diagnosed with nine total MPNSTs. Age range for patients with MPNSTs at time of diagnosis was 22–51, with an average age of 33.4 years. Only one MPNST (11%) developed from underlying pNF 4 years after WBMRI along the right bronchial tree. Three of eight (37.5%) patients with MPNST died within 5 years of pathologic diagnosis.

Conclusion

This study suggests the absence of a predisposition for development of MPNST from pNFs and dNFs in the setting of NF1. As such, these lesions may not need special surveillance compared to discrete peripheral nerve sheath tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Tamura R. Current understanding of neurofibromatosis type 1, 2, and schwannomatosis. Int J Mol Sci. 2021;22(11):5850. https://doi.org/10.3390/ijms22115850. PMID: 34072574; PMCID: PMC8198724.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanné-Chantelot C, Vidaud D, Parfait B, Wolkenstein P. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34(11):1510–8. https://doi.org/10.1002/humu.22392. Epub 2013 Aug 26.

    Article  CAS  PubMed  Google Scholar 

  3. Sørensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986;314(16):1010–5. https://doi.org/10.1056/NEJM198604173141603.

    Article  PubMed  Google Scholar 

  4. Belakhoua SM, Rodriguez FJ. Diagnostic pathology of tumors of peripheral nerve. Neurosurgery. 2021;88(3):443–56. https://doi.org/10.1093/neuros/nyab021. PMID: 33588442; PMCID: PMC7884141.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ahlawat S, Chhabra A, Blakely J. Magnetic resonance neurography of peripheral nerve tumors and tumorlike conditions. Neuroimaging Clin N Am. 2014;24(1):171–92. https://doi.org/10.1016/j.nic.2013.03.035. Epub 2013 May 30.

    Article  PubMed  Google Scholar 

  6. Plotkin SR, Bredella MA, Cai W, Kassarjian A, Harris GJ, Esparza S, Merker VL, Munn LL, Muzikansky A, Askenazi M, Nguyen R, Wenzel R, Mautner VF. Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One. 2012;7(4):e35711. https://doi.org/10.1371/journal.pone.0035711. Epub 2012 Apr 27. PMID: 22558206; PMCID: PMC3338705.

    Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

  7. Monroe CL, Dahiya S, Gutmann DH. Dissecting clinical heterogeneity in neurofibromatosis type 1. Annu Rev Pathol. 2017;24:53–74. https://doi.org/10.1146/annurev-pathol-052016-100228.

    Article  CAS  Google Scholar 

  8. Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE. Patterns of recurrence and survival in sporadic, neurofibromatosis type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg. 2017;126(1):319–29. https://doi.org/10.3171/2015.12.JNS152443. Epub 2016 Apr 1. PMID: 27035165; PMCID: PMC5045773.

    Article  PubMed  Google Scholar 

  9. Lassmann H, Jurecka W, Lassmann G, Gebhart W, Matras H, Watzek G. Different types of benign nerve sheath tumors. Light microscopy, electron microscopy and autoradiography. Virchows Arch A Pathol Anat Histol. 1977;375(3):197–210. https://doi.org/10.1007/BF01102988.

    Article  CAS  PubMed  Google Scholar 

  10. Tucker T, Wolkenstein P, Revuz J, Zeller J, Friedman JM. Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology. 2005;65(2):205–11. https://doi.org/10.1212/01.wnl.0000168830.79997.13.

    Article  CAS  PubMed  Google Scholar 

  11. Ehara Y, Koga M, Imafuku S, Yamamoto O, Yoshida Y. Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1. J Dermatol. 2020;47(2):190–2. https://doi.org/10.1111/1346-8138.15194. Epub 2019 Dec 17.

    Article  PubMed  Google Scholar 

  12. Schaefer IM, Fletcher CD. Malignant peripheral nerve sheath tumor (MPNST) arising in diffuse-type neurofibroma: clinicopathologic characterization in a series of 9 cases. Am J Surg Pathol. 2015;39(9):1234–41.

    Article  PubMed  Google Scholar 

  13. Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol. 2020;49(2):199–219. https://doi.org/10.1007/s00256-019-03290-1. Epub 2019 Aug 8.

    Article  PubMed  Google Scholar 

  14. Azizi AA, Slavc I, Theisen BE, Rausch I, Weber M, Happak W, Aszmann O, Hojreh A, Peyrl A, Amann G, Benkoe TM, Wadsak W, Kasprian G, Staudenherz A, Hacker M, Traub-Weidinger T. Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [18 F]FDG-PET imaging. Is it of value in asymptomatic patients? Pediatr Blood Cancer. 2018;65(1). https://doi.org/10.1002/pbc.26733.

  15. Spurlock G, Knight SJ, Thomas N, Kiehl TR, Guha A, Upadhyaya M. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings. J Cancer Res Clin Oncol. 2010;136(12):1869–80. https://doi.org/10.1007/s00432-010-0846-3. Epub 2010 Mar 15.

    Article  CAS  PubMed  Google Scholar 

  16. Mautner VF, Asuagbor FA, Dombi E, Fünsterer C, Kluwe L, Wenzel R, Widemann BC, Friedman JM. Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol. 2008;10(4):593–8. https://doi.org/10.1215/15228517-2008-011. Epub 2008 Jun 17. PMID: 18559970; PMCID: PMC2666233.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Nguyen R, Kluwe L, Fuensterer C, Kentsch M, Friedrich RE, Mautner VF. Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. J Pediatr. 2011;159(4):652-5.e2. https://doi.org/10.1016/j.jpeds.2011.04.008. Epub 2011 May 31.

    Article  PubMed  Google Scholar 

Download references

Funding

Avneesh Chhabra has received research grant from IBL, Inc. He receives royalties from Wolters and Jaypee Publishers and serves as a medical advisor for IBL, Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Avneesh Chhabra.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Attia, S., Guirguis, M., Le, L.Q. et al. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment. Skeletal Radiol 53, 769–777 (2024). https://doi.org/10.1007/s00256-023-04497-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-023-04497-z

Keywords

Navigation